This report provides comprehensive information on the current therapeutic developmental pipeline of Arromax Pharmatech, Co. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

1. Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014
Global Markets Direct’s, ‘Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014’, provides an overview of the Arromax
Pharmatech, Co. Ltd.’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Arromax Pharmatech, Co. Ltd.’s, complete with
comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It
also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s
team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated
with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking
ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Arromax Pharmatech, Co. Ltd. including business description, key information and facts, and its locations and
subsidiaries The report reviews current pipeline of Arromax Pharmatech, Co. Ltd.’s human therapeutic division and enlists all their major and minor
projects The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental
history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline
projects Latest company statement Latest news and deals relating to the Arromax Pharmatech, Co. Ltd.’s pipeline products Reasons to buy
Evaluate Arromax Pharmatech, Co. Ltd.’s strategic position with total access to detailed information on its product pipeline Assess the growth potential
of Arromax Pharmatech, Co. Ltd. in its therapy areas of focus Identify new drug targets and therapeutic classes in the Arromax Pharmatech, Co. Ltd.’s
R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity
to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Arromax Pharmatech, Co. Ltd. and exploit collaboration and partnership
opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan
mergers and acquisitions effectively by identifying the most promising pipeline of Arromax Pharmatech, Co. Ltd. Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the
dormant and discontinued projects of Arromax Pharmatech, Co. Ltd. and identify potential opportunities in those areas Avoid Intellectual Property Rights related
issues
table Of Content
arromax Pharmatech, Co. Ltd. Snapshot
arromax Pharmatech, Co. Ltd. Overview
key Information
key Facts
arromax Pharmatech, Co. Ltd. - Research And Development Overview
key Therapeutic Areas
arromax Pharmatech, Co. Ltd. - Pipeline Review
pipeline Products By Stage Of Development
pipeline Products - Monotherapy
arromax Pharmatech, Co. Ltd. - Pipeline Products Glance
arromax Pharmatech, Co. Ltd. - Early Stage Pipeline Products
preclinical Products/combination Treatment Modalities
arromax Pharmatech, Co. Ltd. - Drug Profiles
amx-1008
product Description
mechanism Of Action
r&d Progress
amx-2004
product Description
mechanism Of Action
r&d Progress
amx-3002
product Description
mechanism Of Action
r&d Progress
arromax Pharmatech, Co. Ltd. - Pipeline Analysis
arromax Pharmatech, Co. Ltd. - Pipeline Products By Target
arromax Pharmatech, Co. Ltd. - Pipeline Products By Molecule Type
arromax Pharmatech, Co. Ltd. - Pipeline Products By Mechanism Of Action
arromax Pharmatech, Co. Ltd. - Locations And Subsidiaries
head Office
other Locations & Subsidiaries
Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014

2. appendix
methodology
coverage
secondary Research
primary Research
expert Panel Validation
contact Us
disclaimer
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014